Volume 2, Issue 2
COVID Corner
COVID Corner: Helping Patients Cope
This autumn, the International Myeloma Society teamed with the Center of Excellence for Multiple Myeloma at Mount Sinai’s Tisch Cancer...
COVID Corner: Third Vaccination for patients with MM
A third vaccine dose restores immune response against SARS-CoV-2 in patients with multiple myeloma (MM); however, the result is variant-...
Recommendations for anti-Covid-19 vaccination in patients with multiple myeloma (MM) and related conditions, AL amyloidosis and other monoclonal gammopathies of clinical significance
Which patients should get vaccinated? • Data collected by IMS for Covid-19 infection suggest that patients with myeloma are at...
Vaccination against SARS-CoV-2: Suboptimal Response in Myeloma Patients Under Therapy
Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients with hematological malignancies, including CLL and MM. In...
COVID-19 Increases Morbidity and Mortality in Myeloma Patients: One Third of Hospitalized Myeloma Patients Die Because of SARS-CoV-2
COVID-19 pandemic has influenced the clinical care of multiple myeloma (MM) patients. The International Myeloma Society has studied the natural...
